This inventor holds 1 USPTO granted patent. Top assignee: Burroughs Wellcome Co.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Paul Ian Ramage: Innovator in Immunology
Introduction
Paul Ian Ramage is a notable inventor based in Reinach, Switzerland. He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies. His expertise and dedication have led to advancements that may benefit various therapeutic applications.
Latest Patents
Ramage holds a patent for a purified preparation of an anti-CDW52 antibody. This preparation exhibits a single peak under non-reducing conditions and two major peaks under reducing conditions when analyzed through size exclusion chromatography. Additionally, it shows one main band using a non-reduced sample and two main bands using a reduced sample on conventional SDS PAGE. The preparation also demonstrates a single sharp peak under non-reducing conditions and two major peaks under reducing conditions on reversed phase HPLC. Furthermore, the patent includes a process for purifying the anti-CDW52 antibody, formulations containing the purified preparation, and their potential uses.
Career Highlights
Paul Ian Ramage is associated with Burroughs Wellcome Co., where he has been instrumental in advancing research and development in immunology. His work has not only contributed to scientific knowledge but also has practical implications for therapeutic interventions.
Collaborations
Ramage has collaborated with Geoffrey Allen, enhancing the research efforts in their field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving significant breakthroughs.
Conclusion
Paul Ian Ramage's contributions to immunology through his patented work on anti-CDW52 antibodies highlight his role as an innovator in the field. His dedication to research and collaboration continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile